Loading...
Loading...
Longevity Health Holdings, Inc.
Longevity Health Holdings, Inc.. Spoken Alpha tracks XAGE's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks XAGE's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 60% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $0.86 | $0.75 | +14.3% | -0.8% | -3.6% |
| Q4 FY2026 | $0.62 | $0.58 | +6.9% | -7.6% | -10.1% |
| Q3 FY2026 | $0.76 | $0.71 | +7.3% | -2.2% | -3.2% |
| Q2 FY2026 | $0.90 | $0.81 | +10.9% | +1.5% | -0.1% |
| Q1 FY2025 | $0.87 | $0.73 | +19.8% | -6.4% | -5.5% |
| Q4 FY2025 | $0.97 | $0.83 | +16.3% | +2.4% | +4.9% |
| Q3 FY2025 | $0.98 | $0.86 | +14.0% | -2.2% | -4.1% |
| Q2 FY2025 | $0.88 | $0.81 | +8.7% | +2.2% | +2.2% |
| Q1 FY2024 | $0.86 | $0.81 | +5.9% | -6.4% | -4.1% |
| Q4 FY2024 | $0.80 | $0.67 | +18.8% | +2.2% | +4.7% |
Spoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
CEO since 2026 • 1/2 beats (50%) • last guidance cut Q1 FY2026
CEO since 2024 • 3/8 beats (38%) • last call held guidance Q2 FY2026
CEO since 2024 • 3/8 beats (38%) • guidance suspended Q1 FY2026
CFO since 2024 • 3/8 beats (38%) • last guidance raise Q1 FY2026
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for XAGE.
curl https://api.spokenalpha.com/v1/companies/XAGE